spinoff

Panama7/iStock Editorial via Getty Images Sanofi (NASDAQ:SNY) has sought initial bids for its $20B consumer healthcare spinoff as the French drugmaker moves forward with its divestment plans, which include a potential public listing, Bloomberg News reported Tuesday, citing people familiar with the matter. According to the people, the Paris-based pharmaContinue Reading

JHVEPhoto/iStock Editorial via Getty Images GRAIL (GRAL) will begin trading on the Nasdaq as a publicly-listed independent company on Tuesday, after Illumina (NASDAQ:ILMN) completed the spinoff of the cancer test developer following regulatory pressure. It will be listed and begin regular trading on the Nasdaq under the symbol “GRAL” asContinue Reading